EMILIO AGUINALDO COLLEGE

School of Nursing

DRUG STUDY
NAME: Bonilla, Yla Katrina C. PATIENT NAME: F. E. AGE: 45 GENDER: F ROOM NO. 830 DOA: 2/19/2024 DATE: 2/20/2024
STUDENT #: 21-1-00762 DIAGNOSIS: S/P Primary Low Segment CS Myomectomy 2/19
DOSAGE AND CLASSIFCATION MODE OF ACTION INDICATION (for SIDE EFFECTS CONTRAINDICATIONS NURSING RESPONSIBILITIES/
ROUTE OF ADMIN. AND CATEGORY the specific PATIENT TEACHING
disease)

Generic name: A. Chemical: Binds to mu-opioid The combination CNS: Dizziness, • Hypersensitivity • Conduct a thorough pain
Tramadol + Opioid Agonist receptors in CNS, of tramadol and CNS stimulation, to drug, its assessment, considering
Paracetamol inhibiting ascending paracetamol helps somnolence, headache, components, or the patient's pain
pain pathway. manage pain more anxiety, confusion, opioids intensity, location, and
Brand name: Inhibits effectively euphoria, seizures, • Acute characteristics.
reuptake of hallucinations, sedation, intoxication with • Monitor vital signs to
B. Therapeutic norepinephrine, neuroleptic malignant alcohol, assess the overall
Dosage: 37.5 mg Analgesic serotonin, syndrome sedative- response to pain
inhibiting like reactions hypnotics, management.
descending pain CV: Vasodilation, centrally acting • Administer tramadol +
pathways orthostatic hypotension, analgesics, paracetamol as
tachycardia, opioid prescribed by the
Route: PO
hypertension, abnormal analgesics, or healthcare provider.
ECG psychotropic • Follow proper medication
EENT: Visual agents administration
Frequency: BID disturbances • Physical opioid procedures, including
GI: Nausea, dependence checking for allergies and
constipation, vomiting, • Significant potential drug
Pharmacokinetics: dry mouth, diarrhea, respiratory interactions.
Onset: 1 hour abdominal pain, depression, • Monitor the patient for
Peak: 2-3 hour anorexia, flatulence, GI acute or severe potential side effects of
Duration: 4-6 hour bleeding bronchial tramadol (e.g., dizziness,
Half-life: 24 hours GU: Urinary asthma or nausea, constipation)
retention/frequency, hypercapnia in and paracetamol (e.g.,
menopausal symptoms, unmonitored hepatotoxicity).
dysuria, menstrual settings or • Educate the patient to
INTEG: Pruritus, rash, absence of
urticaria, vesicles, report any adverse
effects promptly.
EMILIO AGUINALDO COLLEGE
School of Nursing

flushing resuscitative • Regularly assess the

SYST: Anaphylaxis, equipment effectiveness of pain
Stevens Johnson management and adjust
syndrome, toxic the medication regimen
epidermal necrolysis, as needed.
serotonin syndrome • Encourage open
communication with the
patient regarding pain
levels and relief.
• Encourage early
mobilization to prevent
complications such as
deep vein thrombosis.
• Assist the patient with
safe and gradual
movements to enhance
recovery.
• Implement comfort
measures such as
positioning, supportive
pillows, and warm
compresses as
appropriate.

Patient Teaching:
• Explain the purpose of
tramadol + paracetamol
for pain relief.
• Instruct the patient on the
proper dosage, timing,
and potential side effects.
• Emphasize the
importance of adhering to
the prescribed
medication regimen.
• Teach the patient
relaxation techniques,
EMILIO AGUINALDO COLLEGE
School of Nursing

deep breathing
exercises, and distraction
methods to complement
medication for pain
management.
• Encourage the use of
pain scales for self-
assessment and
communication of pain
levels.
• Provide guidance on safe
and gradual mobilization
to prevent complications.
• Emphasize the
importance of
maintaining mobility
within the prescribed
limits.
• Instruct the patient on
proper hygiene practices
and wound care.
• Provide information on
signs of infection or
complications to monitor
and report.
• Discuss the importance
of attending follow-up
appointments for
assessment and
adjustment of the pain
management plan.
• Provide contact
information for questions
or concerns that may
arise after discharge.
 EMILIO AGUINALDO COLLEGE
School of Nursing

DRUG STUDY

NAME: Bonilla, Yla Katrina C. PATIENT NAME: G. L. AGE: 52 GENDER: F ROOM NO. 842 DOA: 2/10/24 DATE: 2/20/2024
STUDENT #: 21-1-00762 DIAGNOSIS: S/P Multiple Odontectomy; Closure of Oro Antral Communication; Maxillary Bone Recon with Endosteal Implant 2/11
DOSAGE AND CLASSIFCATION MODE OF INDICATION (for SIDE EFFECTS CONTRAINDICATIONS NURSING RESPONSIBILITIES/
ROUTE OF ADMIN. AND CATEGORY ACTION the specific PATIENT TEACHING
disease)

Generic name: C. Chemical: Inhibits COX-2 It can help reduce CNS: Dizziness, • Hypersensitivity • Conduct a comprehensive pain
Celecoxib Nonsteroidal that is needed inflammation and headache, fatigue, to drug, assessment, considering the
cyclooxygenase-2 for prostaglandin swelling associated insomnia sulfonamides, or location, intensity, and nature
(COX-2) inhibitor synthesis; anti- with the surgical CV: Peripheral other NSAIDs of pain.
Brand name: inflammatory, sites. edema, angina, • Advanced renal • Monitor vital signs regularly to
Celebrex bradycardia, disease assess the patient's overall
D. Therapeutic hypotension/hypert • Severe hepatic response to pain and
Anti-Inflammatory ension, palpitations, impairment inflammation.
Dosage: 200 mg HF, MI, stroke, • Sensitivity • Administer celecoxib as
thrombosis, edema precipitated by prescribed, following the
GI: Gingival aspirin healthcare provider's
hyperplasia, instructions.
nausea, abdominal • Assess the patient for any
Route: PO
pain, diarrhea allergies or contraindications to
INTEG: Flushing NSAIDs.
META: • Monitor the patient for potential
Frequency: Q12 Hyperkalemia side effects of celecoxib,
including gastrointestinal
symptoms like nausea or
Pharmacokinetics: abdominal pain.
Onset: Unknown • Educate the patient on
Peak: 3 hour symptoms requiring prompt
Duration:Unknown medical attention.
Half-life: 24 hours • Evaluate the effectiveness of
pain management strategies,
including celecoxib.
• Collaborate with the healthcare
team to adjust the medication
regimen if necessary.
EMILIO AGUINALDO COLLEGE
School of Nursing

• Implement comfort measures

such as positioning, supportive
pillows, and cold compresses
as appropriate.
• Provide pain relief alternatives,
such as relaxation techniques
or distraction methods.
• Encourage adequate fluid
intake to prevent dehydration,
especially if the patient is
taking celecoxib.
• Ensure the patient receives a
balanced diet to support
overall healing.
Patient Teaching:
• Explain the purpose of
celecoxib in managing pain
and inflammation.
• Teach the patient non-
pharmacological pain
management techniques, such
as deep breathing exercises,
guided imagery, or meditation.
• Instruct the patient on the
importance of balancing
activity and rest.
• Provide instructions on proper
wound care if applicable.
• Discuss the need for follow-up
appointments with the
healthcare provider to assess
progress and adjust the
treatment plan.
 EMILIO AGUINALDO COLLEGE
School of Nursing

DRUG STUDY
NAME: Bonilla, Yla Katrina C. PATIENT NAME: G. L. AGE: 52 GENDER: F ROOM NO. 842 DOA: 2/10/24 DATE: 2/20/2024
STUDENT #: 21-1-00762 DIAGNOSIS: S/P Multiple Odontectomy; Closure of Oro Antral Communication; Maxillary Bone Recon with Endosteal Implant 2/11
DOSAGE AND CLASSIFCATION MODE OF ACTION INDICATION (for SIDE EFFECTS CONTRAINDICATIONS NURSING RESPONSIBILITIES/
ROUTE OF ADMIN. AND CATEGORY the specific PATIENT TEACHING
disease)

Generic name: E. Chemical: The combination of To prevent CNS: Nausea, • Contraindicated • Conduct a thorough patient
Co-amoxiclav Beta-lactam and amoxicillin and bacterial Vomiting, in individuals assessment, including
Beta-lactamase clavulanic acid in co- infections at the Headache with a history of allergies, medical history, and
inhibitor amoxiclav enhances surgical sites CV: Chest pain, allergic reactions current medications.
Brand name: the efficacy of the following multiple palpitations to penicillin or • Monitor vital signs regularly,
Augmentin antibiotic against a odontectomy, GI: Diarrhea, cephalosporin especially during the initial
broader range of closure of Gas, Stomach antibiotics. administration.
F. Therapeutic:
bacteria, including oroantral pain • Patients with • Administer co-amoxiclav as
Antibiotic
those that produce communication, severe liver prescribed, ensuring the
Dosage: 1 g beta-lactamase. This and maxillary dysfunction. correct dosage and route.
combination is bone • Avoid in patients • Verify patient allergies to
particularly useful in reconstruction. who have penicillin or cephalosporins
treating infections experienced before administration.
Route: PO where beta- jaundice or • Observe for signs of allergic
lactamase-producing hepatic reactions, such as rash, itching,
bacteria are a dysfunction swelling, or difficulty breathing.
concern, improving associated with
Frequency: BID • Monitor liver function through
the overall the use of co- regular assessments for signs
antimicrobial amoxiclav. of hepatic dysfunction.
coverage. • Individuals with a
Pharmacokinetics: • Explain the purpose of co-
history of amoxiclav, emphasizing
Onset: Unknown cholestatic
Peak: 6 hours adherence to the prescribed
jaundice or dosage and duration.
Duration: Over 24 hepatic
hours • Educate the patient on
impairment
Half-life: 24 hours potential side effects and when
related to co-
to seek medical attention.
amoxiclav use.
• Ensure proper documentation
• Known history of
of any known allergies,
colitis or
especially to penicillin or
EMILIO AGUINALDO COLLEGE
School of Nursing

gastrointestinal cephalosporins, in the patient's

disease medical record.
associated with • Monitor renal function in
Clostridium patients with pre-existing renal
difficile infection. impairment, as dosage
adjustments may be necessary.
Patient Teaching:
• Emphasize the importance of
taking co-amoxiclav exactly as
prescribed, even if symptoms
improve before completing the
course.
• Instruct the patient to report
any signs of allergic reactions
promptly, including rash,
itching, swelling, or difficulty
breathing.
• Educate the patient about
common side effects such as
gastrointestinal symptoms
(nausea, diarrhea) and when to
notify healthcare providers.
• Advise the patient to avoid
alcohol consumption during co-
amoxiclav treatment to prevent
potential interactions.
 EMILIO AGUINALDO COLLEGE
School of Nursing

NAME: Bonilla, Yla Katrina C. PATIENT NAME: G. L. AGE: 52 GENDER: F ROOM NO. 842 DOA: 2/10/24 DATE: 2/20/2024
STUDENT #: 21-1-00762 DIAGNOSIS: S/P Multiple Odontectomy; Closure of Oro Antral Communication; Maxillary Bone Recon with Endosteal Implant 2/11
DOSAGE AND CLASSIFCATION MODE OF ACTION INDICATION SIDE EFFECTS CONTRAINDICATIONS NURSING RESPONSIBILITIES/
ROUTE OF ADMIN. AND CATEGORY (for the PATIENT TEACHING
specific
disease)
Generic name: A. Chemical: Binds to mu-opioid The CNS: Dizziness, • Hypersensitivity • Conduct a thorough pain
Paracetamol + Opioid Agonist receptors in CNS, combination CNS stimulation, to drug, its assessment, considering the
Tramadol inhibiting ascending of tramadol somnolence, components, or patient's pain intensity, location,
pain pathway. and headache, anxiety, opioids and characteristics.
B. Therapeutic Inhibits paracetamol confusion, • Acute • Monitor vital signs to assess the
Brand name: Analgesic reuptake of helps manage euphoria, seizures, intoxication with overall response to pain
norepinephrine, pain more hallucinations, alcohol, management.
serotonin, effectively sedation, neuroleptic sedative- • Administer tramadol +
inhibiting malignant syndrome hypnotics, paracetamol as prescribed by
Dosage: 35.5 mg descending pain like reactions centrally acting the healthcare provider.
pathways CV: Vasodilation, analgesics, • Follow proper medication
orthostatic opioid administration procedures,
hypotension, analgesics, or including checking for allergies
Route: PO tachycardia, psychotropic and potential drug interactions.
hypertension, agents • Monitor the patient for potential
abnormal ECG • Physical opioid side effects of tramadol (e.g.,
EENT: Visual dependence dizziness, nausea, constipation)
Frequency: BID disturbances • Significant and paracetamol (e.g.,
GI: Nausea, respiratory hepatotoxicity).
constipation, depression, • Educate the patient to report
Pharmacokinetics: vomiting, dry mouth, acute or severe any adverse effects promptly.
Onset: 1 hour diarrhea, abdominal bronchial asthma
Peak: 2-3 hour pain, • Regularly assess the
or hypercapnia effectiveness of pain
Duration: 4-6 hour anorexia, flatulence, in unmonitored
Half-life: 24 hours GI bleeding management and adjust the
settings or medication regimen as needed.
GU: Urinary absence of
retention/frequency, • Encourage open communication
resuscitative
menopausal with the patient regarding pain
equipment
symptoms, dysuria, levels and relief.
menstrual
EMILIO AGUINALDO COLLEGE
School of Nursing

INTEG: Pruritus, rash, • Encourage early mobilization to

urticaria, vesicles, prevent complications such as
flushing deep vein thrombosis.
SYST: Anaphylaxis, • Assist the patient with safe and
Stevens Johnson gradual movements to enhance
syndrome, toxic recovery.
epidermal necrolysis, • Implement comfort measures
serotonin syndrome such as positioning, supportive
pillows, and warm compresses
as appropriate.

Patient Teaching:
• Explain the purpose of tramadol
+ paracetamol for pain relief.
• Instruct the patient on the
proper dosage, timing, and
potential side effects.
• Emphasize the importance of
adhering to the prescribed
medication regimen.
• Teach the patient relaxation
techniques, deep breathing
exercises, and distraction
methods to complement
medication for pain
management.
• Encourage the use of pain
scales for self-assessment and
communication of pain levels.